Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults

Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels of cerebrospinal fluid tau in women compared with men as a function of apolipoprotein E (APOE) ε4 status and β-amyloid (Aβ). What remains unclear is the...

Full description

Saved in:
Bibliographic Details
Published inArchives of neurology (Chicago) Vol. 76; no. 5; p. 542
Main Authors Buckley, Rachel F, Mormino, Elizabeth C, Rabin, Jennifer S, Hohman, Timothy J, Landau, Susan, Hanseeuw, Bernard J, Jacobs, Heidi I L, Papp, Kathryn V, Amariglio, Rebecca E, Properzi, Michael J, Schultz, Aaron P, Kirn, Dylan, Scott, Matthew R, Hedden, Trey, Farrell, Michelle, Price, Julie, Chhatwal, Jasmeer, Rentz, Dorene M, Villemagne, Victor L, Johnson, Keith A, Sperling, Reisa A
Format Journal Article
LanguageEnglish
Published United States American Medical Association 01.05.2019
Subjects
Online AccessGet full text
ISSN2168-6149
2168-6157
DOI10.1001/jamaneurol.2018.4693

Cover

Abstract Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels of cerebrospinal fluid tau in women compared with men as a function of apolipoprotein E (APOE) ε4 status and β-amyloid (Aβ). What remains unclear is the association of sex with regional tau deposition in clinically normal individuals. To examine sex differences in the cross-sectional association between Aβ and regional tau deposition as measured with positron emission tomography (PET). This is a study of 2 cross-sectional, convenience-sampled cohorts of clinically normal individuals who received tau and Aβ PET scans. Data were collected between January 2016 and February 2018 from 193 clinically normal individuals from the Harvard Aging Brain Study (age range, 55-92 years; 118 women [61%]) who underwent carbon 11-labeled Pittsburgh Compound B and flortaucipir F18 PET and 103 clinically normal individuals from the Alzheimer's Disease Neuroimaging Initiative (age range, 63-94 years; 55 women [51%]) who underwent florbetapir and flortaucipir F 18 PET. A main association of sex with regional tau in the entorhinal cortices, inferior temporal lobe, and a meta-region of interest, which was a composite of regions in the temporal lobe. Associations between sex and global Aβ as well as sex and APOE ε4 on these regions after controlling for age were also examined. The mean (SD) age of all individuals was 74.2 (7.6) years (81 APOE ε4 carriers [31%]; 89 individuals [30%] with high Aβ). There was no clear association of sex with regional tau that was replicated across studies. However, in both cohorts, clinically normal women exhibited higher entorhinal cortical tau than men (meta-analytic estimate: β [male] = -0.11 [0.05]; 95% CI, -0.21 to -0.02; P = .02), which was associated with individuals with higher Aβ burden. A sex by APOE ε4 interaction was not associated with regional tau (meta-analytic estimate: β [male, APOE ε4+] = -0.15 [0.09]; 95% CI, -0.32 to 0.01; P = .07). Early tau deposition was elevated in women compared with men in individuals on the Alzheimer disease trajectory. These findings lend support to a growing body of literature that highlights a biological underpinning for sex differences in Alzheimer disease risk.
AbstractList Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels of cerebrospinal fluid tau in women compared with men as a function of apolipoprotein E (APOE) ε4 status and β-amyloid (Aβ). What remains unclear is the association of sex with regional tau deposition in clinically normal individuals. To examine sex differences in the cross-sectional association between Aβ and regional tau deposition as measured with positron emission tomography (PET). This is a study of 2 cross-sectional, convenience-sampled cohorts of clinically normal individuals who received tau and Aβ PET scans. Data were collected between January 2016 and February 2018 from 193 clinically normal individuals from the Harvard Aging Brain Study (age range, 55-92 years; 118 women [61%]) who underwent carbon 11-labeled Pittsburgh Compound B and flortaucipir F18 PET and 103 clinically normal individuals from the Alzheimer's Disease Neuroimaging Initiative (age range, 63-94 years; 55 women [51%]) who underwent florbetapir and flortaucipir F 18 PET. A main association of sex with regional tau in the entorhinal cortices, inferior temporal lobe, and a meta-region of interest, which was a composite of regions in the temporal lobe. Associations between sex and global Aβ as well as sex and APOE ε4 on these regions after controlling for age were also examined. The mean (SD) age of all individuals was 74.2 (7.6) years (81 APOE ε4 carriers [31%]; 89 individuals [30%] with high Aβ). There was no clear association of sex with regional tau that was replicated across studies. However, in both cohorts, clinically normal women exhibited higher entorhinal cortical tau than men (meta-analytic estimate: β [male] = -0.11 [0.05]; 95% CI, -0.21 to -0.02; P = .02), which was associated with individuals with higher Aβ burden. A sex by APOE ε4 interaction was not associated with regional tau (meta-analytic estimate: β [male, APOE ε4+] = -0.15 [0.09]; 95% CI, -0.32 to 0.01; P = .07). Early tau deposition was elevated in women compared with men in individuals on the Alzheimer disease trajectory. These findings lend support to a growing body of literature that highlights a biological underpinning for sex differences in Alzheimer disease risk.
Importance Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels of cerebrospinal fluid tau in women compared with men as a function of apolipoprotein E (APOE) ε4 status and β-amyloid (Aβ). What remains unclear is the association of sex with regional tau deposition in clinically normal individuals. Objective To examine sex differences in the cross-sectional association between Aβ and regional tau deposition as measured with positron emission tomography (PET). Design, Setting and Participants This is a study of 2 cross-sectional, convenience-sampled cohorts of clinically normal individuals who received tau and Aβ PET scans. Data were collected between January 2016 and February 2018 from 193 clinically normal individuals from the Harvard Aging Brain Study (age range, 55-92 years; 118 women [61%]) who underwent carbon 11–labeled Pittsburgh Compound B and flortaucipir F18 PET and 103 clinically normal individuals from the Alzheimer’s Disease Neuroimaging Initiative (age range, 63-94 years; 55 women [51%]) who underwent florbetapir and flortaucipir F 18 PET. Main Outcomes and Measures A main association of sex with regional tau in the entorhinal cortices, inferior temporal lobe, and a meta-region of interest, which was a composite of regions in the temporal lobe. Associations between sex and global Aβ as well as sex and APOE ε4 on these regions after controlling for age were also examined. Results The mean (SD) age of all individuals was 74.2 (7.6) years (81 APOE ε4 carriers [31%]; 89 individuals [30%] with high Aβ). There was no clear association of sex with regional tau that was replicated across studies. However, in both cohorts, clinically normal women exhibited higher entorhinal cortical tau than men (meta-analytic estimate: β [male] = −0.11 [0.05]; 95% CI, −0.21 to −0.02; P = .02), which was associated with individuals with higher Aβ burden. A sex by APOE ε4 interaction was not associated with regional tau (meta-analytic estimate: β [male, APOE ε4+] = −0.15 [0.09]; 95% CI, −0.32 to 0.01; P = .07). Conclusions and Relevance Early tau deposition was elevated in women compared with men in individuals on the Alzheimer disease trajectory. These findings lend support to a growing body of literature that highlights a biological underpinning for sex differences in Alzheimer disease risk.
Author Buckley, Rachel F
Farrell, Michelle
Papp, Kathryn V
Johnson, Keith A
Hohman, Timothy J
Jacobs, Heidi I L
Kirn, Dylan
Schultz, Aaron P
Hedden, Trey
Mormino, Elizabeth C
Rabin, Jennifer S
Hanseeuw, Bernard J
Amariglio, Rebecca E
Scott, Matthew R
Rentz, Dorene M
Villemagne, Victor L
Properzi, Michael J
Landau, Susan
Chhatwal, Jasmeer
Sperling, Reisa A
Price, Julie
Author_xml – sequence: 1
  givenname: Rachel F
  surname: Buckley
  fullname: Buckley, Rachel F
  organization: Melbourne School of Psychological Science, University of Melbourne, Victoria, Australia
– sequence: 2
  givenname: Elizabeth C
  surname: Mormino
  fullname: Mormino, Elizabeth C
  organization: Department of Neurology, Stanford University, Stanford, California
– sequence: 3
  givenname: Jennifer S
  surname: Rabin
  fullname: Rabin, Jennifer S
  organization: Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston
– sequence: 4
  givenname: Timothy J
  surname: Hohman
  fullname: Hohman, Timothy J
  organization: Vanderbilt Memory & Alzheimer's Center, Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee
– sequence: 5
  givenname: Susan
  surname: Landau
  fullname: Landau, Susan
  organization: Helen Wills Neuroscience Institute, University of California Berkeley, Berkeley
– sequence: 6
  givenname: Bernard J
  surname: Hanseeuw
  fullname: Hanseeuw, Bernard J
  organization: Department of Neurology, Cliniques Universitaires St-Luc, Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium
– sequence: 7
  givenname: Heidi I L
  surname: Jacobs
  fullname: Jacobs, Heidi I L
  organization: Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston
– sequence: 8
  givenname: Kathryn V
  surname: Papp
  fullname: Papp, Kathryn V
  organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 9
  givenname: Rebecca E
  surname: Amariglio
  fullname: Amariglio, Rebecca E
  organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 10
  givenname: Michael J
  surname: Properzi
  fullname: Properzi, Michael J
  organization: Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
– sequence: 11
  givenname: Aaron P
  surname: Schultz
  fullname: Schultz, Aaron P
  organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 12
  givenname: Dylan
  surname: Kirn
  fullname: Kirn, Dylan
  organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 13
  givenname: Matthew R
  surname: Scott
  fullname: Scott, Matthew R
  organization: Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
– sequence: 14
  givenname: Trey
  surname: Hedden
  fullname: Hedden, Trey
  organization: Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston
– sequence: 15
  givenname: Michelle
  surname: Farrell
  fullname: Farrell, Michelle
  organization: Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
– sequence: 16
  givenname: Julie
  surname: Price
  fullname: Price, Julie
  organization: Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston
– sequence: 17
  givenname: Jasmeer
  surname: Chhatwal
  fullname: Chhatwal, Jasmeer
  organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 18
  givenname: Dorene M
  surname: Rentz
  fullname: Rentz, Dorene M
  organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts
– sequence: 19
  givenname: Victor L
  surname: Villemagne
  fullname: Villemagne, Victor L
  organization: Department of Nuclear Medicine and Centre for PET, Austin Health, Victoria, Australia
– sequence: 20
  givenname: Keith A
  surname: Johnson
  fullname: Johnson, Keith A
  organization: Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston
– sequence: 21
  givenname: Reisa A
  surname: Sperling
  fullname: Sperling, Reisa A
  organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30715078$$D View this record in MEDLINE/PubMed
BookMark eNo9kMtOwzAQRS0EolD6BwhZYt3iV5xkWbXlIZWHoKwrJx6DKycudiKRb-FnSaEwmxmde3VHM6fosPY1IHROyYQSQq82qlI1tMG7CSM0mwiZ8wN0wqjMxpIm6eH_LPIBGsW4IX1lhAgujtGAk5QmJM1O0NcLfOK5NQYC1CVEbGvcvAOexuhLqxrra-wNvnG-UA5Pq855q7GqNX6Gt17s4Uq1eA5bH-2P-x5UbANoXHT4aQdDDxeVjXGnrnzl34Lavne7TTNna1sq5zr84EPVhz06DQFPdeuaeIaOjHIRRvs-RK_Xi9Xsdrx8vLmbTZdjlTDajMskldSkkmWSUTA8V7Q0GpJUa6kILVLBpdFK81wUJhcZYzkUGaU6oyllXPMhuvzN3Qb_0UJs1hvfhv60uGZMJFLkCZe962LvaosK9HobbKVCt_77Jf8GaZF84g
CitedBy_id crossref_primary_10_1186_s13195_022_01106_4
crossref_primary_10_1016_j_neuroimage_2022_119761
crossref_primary_10_1186_s13195_022_00973_1
crossref_primary_10_1177_0271678X211062274
crossref_primary_10_1126_scitranslmed_aaz5677
crossref_primary_10_3389_fnagi_2024_1480332
crossref_primary_10_1016_j_neurobiolaging_2021_03_007
crossref_primary_10_1016_j_parkreldis_2023_105454
crossref_primary_10_1007_s00259_020_05099_w
crossref_primary_10_1093_braincomms_fcaa025
crossref_primary_10_1016_S0140_6736_20_31561_0
crossref_primary_10_1007_s11357_022_00588_2
crossref_primary_10_1016_j_nicl_2019_102025
crossref_primary_10_1007_s11357_023_00982_4
crossref_primary_10_1016_j_arr_2021_101459
crossref_primary_10_1111_ene_14174
crossref_primary_10_1016_j_neurobiolaging_2021_03_010
crossref_primary_10_1002_alz_13158
crossref_primary_10_1016_j_nicl_2023_103532
crossref_primary_10_1002_jnr_24739
crossref_primary_10_3389_fnagi_2021_691691
crossref_primary_10_1001_jamaneurol_2019_2899
crossref_primary_10_1093_braincomms_fcab126
crossref_primary_10_1093_braincomms_fcad305
crossref_primary_10_1093_brain_awad317
crossref_primary_10_1002_alz_12501
crossref_primary_10_1002_trc2_12154
crossref_primary_10_3233_JAD_190465
crossref_primary_10_1002_ana_25878
crossref_primary_10_3389_fnagi_2019_00242
crossref_primary_10_1088_1741_2552_ac37cc
crossref_primary_10_1186_s12974_024_03020_y
crossref_primary_10_3390_genes12060917
crossref_primary_10_1016_S1474_4422_22_00408_2
crossref_primary_10_3390_neuroglia6010002
crossref_primary_10_1002_alz_12952
crossref_primary_10_1080_14740338_2024_2448205
crossref_primary_10_3389_fnins_2022_954999
crossref_primary_10_3390_ijms24076354
crossref_primary_10_3233_ADR_200214
crossref_primary_10_3390_v15061319
crossref_primary_10_1007_s12264_021_00814_5
crossref_primary_10_1016_j_brainres_2019_146385
crossref_primary_10_1159_000507977
crossref_primary_10_1242_dmm_045211
crossref_primary_10_1186_s13195_023_01162_4
crossref_primary_10_1016_j_neuron_2024_01_024
crossref_primary_10_1002_gps_5809
crossref_primary_10_3390_genes14040917
crossref_primary_10_1016_j_neurobiolaging_2021_04_003
crossref_primary_10_1016_j_neuint_2023_105499
crossref_primary_10_1001_jamaneurol_2021_5181
crossref_primary_10_3233_JAD_230527
crossref_primary_10_1038_s41380_024_02838_5
crossref_primary_10_1093_cercor_bhac491
crossref_primary_10_3389_fnsys_2021_685957
crossref_primary_10_1002_alz_70004
crossref_primary_10_3233_JAD_231186
crossref_primary_10_3389_fnagi_2022_829202
crossref_primary_10_1016_j_neurobiolaging_2023_06_013
crossref_primary_10_1089_neur_2023_0051
crossref_primary_10_1053_j_semnuclmed_2024_01_010
crossref_primary_10_1155_2024_8839631
crossref_primary_10_1177_00914150241253257
crossref_primary_10_1001_jamaneurol_2023_0455
crossref_primary_10_1002_alz_12662
crossref_primary_10_1186_s13293_024_00620_4
crossref_primary_10_1007_s00259_023_06280_7
crossref_primary_10_1002_alz_12422
crossref_primary_10_3390_brainsci13081195
crossref_primary_10_1212_WNL_0000000000200137
crossref_primary_10_3389_fgwh_2023_1289096
crossref_primary_10_1177_1535370220920552
crossref_primary_10_3389_fnins_2020_525970
crossref_primary_10_1007_s13311_021_01026_5
crossref_primary_10_1016_j_neuroimage_2022_119621
crossref_primary_10_1186_s13195_024_01601_w
crossref_primary_10_1002_alz_12989
crossref_primary_10_1016_j_bbi_2020_05_014
crossref_primary_10_1002_alz_13844
crossref_primary_10_3233_JAD_215273
crossref_primary_10_1002_dad2_12211
crossref_primary_10_1016_j_arr_2021_101542
crossref_primary_10_1093_brain_awac257
crossref_primary_10_2967_jnumed_120_261881
crossref_primary_10_1093_brain_awad100
crossref_primary_10_1016_j_neurot_2024_e00426
crossref_primary_10_1001_jamaneurol_2019_5154
crossref_primary_10_1093_brain_awab160
crossref_primary_10_1097_QAI_0000000000003184
crossref_primary_10_1016_S1474_4422_23_00128_X
crossref_primary_10_1001_jamaneurol_2023_4038
crossref_primary_10_1186_s13550_024_01193_4
crossref_primary_10_1002_alz_12759
crossref_primary_10_1515_revneuro_2023_0108
crossref_primary_10_1016_j_neurobiolaging_2022_05_003
crossref_primary_10_1002_dad2_12565
crossref_primary_10_1038_s41380_024_02753_9
crossref_primary_10_1002_ana_26382
crossref_primary_10_1186_s13195_024_01509_5
crossref_primary_10_3233_JAD_215260
crossref_primary_10_1073_pnas_1904673116
crossref_primary_10_1007_s00330_023_10366_z
crossref_primary_10_1007_s13311_023_01408_x
crossref_primary_10_1002_alz_12087
crossref_primary_10_1212_WNL_0000000000011081
crossref_primary_10_1016_j_nicl_2021_102708
crossref_primary_10_1186_s13195_022_01081_w
crossref_primary_10_1177_0271678X231196978
crossref_primary_10_1007_s11920_020_01202_y
crossref_primary_10_1186_s13293_020_00310_x
crossref_primary_10_1002_acn3_51102
crossref_primary_10_1186_s13024_022_00590_4
crossref_primary_10_1126_sciadv_adt1288
crossref_primary_10_1038_s44321_024_00190_3
crossref_primary_10_1186_s13195_021_00902_8
crossref_primary_10_1002_alz_13546
crossref_primary_10_1073_pnas_2406854121
crossref_primary_10_1162_imag_a_00369
crossref_primary_10_1186_s13195_023_01178_w
crossref_primary_10_1126_sciadv_adt0757
crossref_primary_10_1001_jamaneurol_2024_2843
crossref_primary_10_1038_s41591_023_02380_x
crossref_primary_10_15252_emmm_202012921
crossref_primary_10_3389_frdem_2024_1496051
crossref_primary_10_1212_WNL_0000000000009781
crossref_primary_10_1002_dad2_12271
crossref_primary_10_1007_s00259_020_05118_w
crossref_primary_10_1016_j_neurobiolaging_2021_05_013
crossref_primary_10_1002_alz_13432
crossref_primary_10_3233_ADR_230131
crossref_primary_10_1016_j_mad_2023_111821
crossref_primary_10_3390_ijms24032166
crossref_primary_10_1002_alz_14405
crossref_primary_10_1002_alz_13314
crossref_primary_10_1093_brain_awaa327
crossref_primary_10_1016_j_biopsych_2023_09_003
crossref_primary_10_3233_JAD_210434
crossref_primary_10_3233_JAD_220905
crossref_primary_10_1093_brain_awad397
crossref_primary_10_1212_WNL_0000000000008682
crossref_primary_10_1002_dmrr_3401
crossref_primary_10_1007_s12035_021_02591_8
crossref_primary_10_1212_WNL_0000000000010527
crossref_primary_10_3390_ijms242417377
crossref_primary_10_1186_s13195_024_01446_3
crossref_primary_10_1002_alz_12552
crossref_primary_10_1016_j_psyneuen_2021_105248
crossref_primary_10_1002_dad2_12016
crossref_primary_10_1186_s13195_025_01684_z
crossref_primary_10_1111_jnc_15834
crossref_primary_10_1016_j_yfrne_2025_101184
crossref_primary_10_1016_j_dadm_2019_07_007
crossref_primary_10_1186_s13024_021_00452_5
crossref_primary_10_3233_JAD_210341
crossref_primary_10_1016_j_cell_2022_09_002
crossref_primary_10_3390_biom14121518
crossref_primary_10_1007_s00401_020_02152_8
crossref_primary_10_1001_jamaneurol_2019_4421
crossref_primary_10_1038_s41582_019_0228_7
crossref_primary_10_1016_S0140_6736_20_32205_4
crossref_primary_10_3390_life13081676
crossref_primary_10_1017_S1355617721000801
crossref_primary_10_1002_dad2_12121
crossref_primary_10_1001_jamanetworkopen_2019_13909
crossref_primary_10_1038_s44294_024_00021_3
crossref_primary_10_3389_fnagi_2022_825996
crossref_primary_10_3389_fnimg_2022_978350
crossref_primary_10_1002_ana_26588
crossref_primary_10_1001_jamanetworkopen_2021_1001
crossref_primary_10_1016_j_nicl_2021_102620
crossref_primary_10_1177_1756286419888819
crossref_primary_10_1126_sciadv_adt9243
crossref_primary_10_1002_alz_14435
crossref_primary_10_1093_brain_awac316
crossref_primary_10_1016_j_cell_2022_09_029
crossref_primary_10_1016_j_neurobiolaging_2020_08_020
crossref_primary_10_1186_s13024_020_00413_4
crossref_primary_10_1001_jamanetworkopen_2021_24124
crossref_primary_10_1002_alz_13460
crossref_primary_10_3390_biom13010026
crossref_primary_10_53053_SSNO9455
crossref_primary_10_1016_j_neurobiolaging_2023_10_002
crossref_primary_10_1016_j_neurobiolaging_2021_01_026
crossref_primary_10_1016_j_tem_2021_09_004
crossref_primary_10_1186_s13195_024_01653_y
crossref_primary_10_3233_JAD_201014
crossref_primary_10_1002_trc2_12080
crossref_primary_10_1073_pnas_2416042122
crossref_primary_10_1007_s00259_019_04669_x
crossref_primary_10_3390_biom13071115
crossref_primary_10_1002_hup_2838
crossref_primary_10_1016_j_jarlif_2025_100001
crossref_primary_10_1038_s41746_023_00978_6
crossref_primary_10_1093_cercor_bhae299
crossref_primary_10_3233_JAD_200293
crossref_primary_10_3390_ijms25073964
crossref_primary_10_1093_sleep_zsac135
crossref_primary_10_1186_s12974_025_03404_8
crossref_primary_10_1001_jamaneurol_2023_1059
crossref_primary_10_1001_jamaneurol_2025_0013
crossref_primary_10_1016_j_neuroimage_2020_116944
crossref_primary_10_1289_EHP8428
crossref_primary_10_3233_JAD_200723
crossref_primary_10_1186_s12974_020_02046_2
crossref_primary_10_7554_eLife_81067
crossref_primary_10_1038_s41467_020_15701_2
crossref_primary_10_3233_JAD_191183
crossref_primary_10_3233_JAD_210406
crossref_primary_10_1016_j_neurobiolaging_2021_12_010
crossref_primary_10_1093_cercor_bhae067
crossref_primary_10_1007_s12264_022_00836_7
crossref_primary_10_1002_alz_13454
crossref_primary_10_2147_NDT_S403854
crossref_primary_10_1002_dad2_12284
crossref_primary_10_1097_WAD_0000000000000393
crossref_primary_10_1212_NXG_0000000000200043
crossref_primary_10_3389_fphar_2021_746491
crossref_primary_10_1186_s13195_022_00991_z
crossref_primary_10_1016_j_jphs_2021_03_006
ContentType Journal Article
Copyright Copyright American Medical Association May 2019
Copyright_xml – notice: Copyright American Medical Association May 2019
DBID CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U7
C1K
K9.
NAPCQ
DOI 10.1001/jamaneurol.2018.4693
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Toxicology Abstracts
Neurosciences Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2168-6157
ExternalDocumentID 30715078
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: K01 AG049164
– fundername: NIA NIH HHS
  grantid: P30 AG062421
– fundername: NIA NIH HHS
  grantid: P01 AG036694
– fundername: NIA NIH HHS
  grantid: K24 AG035007
– fundername: NIA NIH HHS
  grantid: R01 AG046396
– fundername: NIA NIH HHS
  grantid: K99 AG061238
– fundername: NIA NIH HHS
  grantid: K01 AG051718
– fundername: NIA NIH HHS
  grantid: R01 AG059716
– fundername: NIA NIH HHS
  grantid: R21 AG059941
– fundername: NIA NIH HHS
  grantid: R00 AG061238
GroupedDBID 0R~
4.4
53G
AAGZG
ABIVO
ABJNI
ACDNT
ACGFS
ACPRK
ADBBV
ADHGD
AENEX
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AMJDE
ANMPU
BRYMA
C45
CGR
CUY
CVF
EBD
EBS
ECM
EIF
EJD
EMOBN
EX3
H13
NPM
OB2
OBH
OHH
OVD
PQQKQ
RAJ
SV3
TEORI
WOW
---
-QF
.XZ
23N
2WC
354
39C
5GY
6J9
7TK
7U7
AAWTL
ABCQX
ABOCM
ACGFO
AFOSN
C1A
C1K
CS3
E3Z
EAM
F5P
GX1
K9.
L7B
MJL
N9A
NAPCQ
P2P
RXW
SJN
TWZ
VVN
WH7
X6Y
XHN
YOC
ZY1
ID FETCH-LOGICAL-a521t-c5761f7628621ef39a1cfde57dd6a01b7436fdad394bf948229eb811d817123d3
ISSN 2168-6149
IngestDate Sat Jul 26 02:16:19 EDT 2025
Thu Apr 03 07:07:33 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a521t-c5761f7628621ef39a1cfde57dd6a01b7436fdad394bf948229eb811d817123d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink http://hdl.handle.net/2078/213494
PMID 30715078
PQID 2245649536
PQPubID 42446
ParticipantIDs proquest_journals_2245649536
pubmed_primary_30715078
PublicationCentury 2000
PublicationDate 2019-05-01
PublicationDateYYYYMMDD 2019-05-01
PublicationDate_xml – month: 05
  year: 2019
  text: 2019-05-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Chicago
PublicationTitle Archives of neurology (Chicago)
PublicationTitleAlternate JAMA Neurol
PublicationYear 2019
Publisher American Medical Association
Publisher_xml – name: American Medical Association
SSID ssj0000800434
ssj0012889
Score 2.663492
Snippet Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels of...
Importance Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 542
SubjectTerms Age
Aged
Aged, 80 and over
Aging
Alzheimer's disease
Amyloid beta-Peptides - metabolism
Aniline Compounds
Apolipoprotein E
Apolipoprotein E4 - genetics
Brain
Brain - diagnostic imaging
Brain - metabolism
Carbolines
Cerebrospinal fluid
Contrast Media
Cortex
Cross-Sectional Studies
Deposition
Emission analysis
Emission measurements
Entorhinal Cortex - diagnostic imaging
Entorhinal Cortex - metabolism
Ethylene Glycols
Female
Gender aspects
Gender differences
Health risks
Healthy Volunteers
Humans
Male
Medical imaging
Men
Middle Aged
Neurodegenerative diseases
Neuroimaging
Neurology
Older people
Positron emission
Positron emission tomography
Regional analysis
Sex
Sex differences
Sex Factors
Tau protein
tau Proteins - metabolism
Temporal lobe
Temporal Lobe - diagnostic imaging
Temporal Lobe - metabolism
Thiazoles
Tomography
Trajectories
Women
β-Amyloid
Title Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults
URI https://www.ncbi.nlm.nih.gov/pubmed/30715078
https://www.proquest.com/docview/2245649536
Volume 76
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swEBZZB2MvY7_brhv3sLfgUMe2LD-GkRJGnZbNgbwZy5K3QhOPJoF1_0r_tv0vu5Pk2Ml-sO1FBEHsoPsi3Z2--46xtzooE14FhVcmAgOUsFCeKHEz5IFOhFZULUq1w-mUT2bh-3k07_W-d1hLm7UclN9-WVfyP1bFObQrVcn-g2W3D8UJ_Iz2xREtjONf2fij_op7VuVK9lYNZ7Gz5OQLWln__miBsfmVchWJn2wKMCs2uOU0zK1-ajOGxim9pMkbnBwjFCin1s_qhRO4NrWCrqby-pYufxb4sAvq-N0fkaLHquv0dtVtjX6mkX2i62PLA-lkI9xVszE8SU1ft8zjtCbaTr3DRWtzvB8K6fqKObpOm9Od1J9dmtcB012FuVwHlVdFO7yR_UusfQibfXPoc4ERsVVCHejunNXCbjZ-23jGATzq7OKRFfz66XRpuxrYxSJmoBiE3PZ43BXznl7kZ7Pz8zwbz7N77P4wRteOatHnWwYSegamQ-P2924rO60o1v47fh8DGV8oe8weuSAGRhaRT1hPL5-yB6mjaTxjdwhM6AATrpaAwITOQkJdgQUmOGACAhMaYAICE1pgQgNMkLfQABMaYEILTHpTC0ywwAQDTLDAfM5mZ-Ps3cRzXUC8gppteCVGxH4VUwn10NdVkBR-WSkdxUrx4tSX6ALzShUqSEJZJSE1MNBS-L4SfoxumQpesINlvdSHDKJEa67DSpScHNdCyFiGpyWeY5FEI-gjdtKscO7-5qt8SNQAYmHzI_bSrnr-xSrB5HhAUkAljv_8xVfsYYvmE3awvtno1-jLruUbgwgcp5fpD0zjqMk
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sex+Differences+in+the+Association+of+Global+Amyloid+and+Regional+Tau+Deposition+Measured+by+Positron+Emission+Tomography+in+Clinically+Normal+Older+Adults&rft.jtitle=Archives+of+neurology+%28Chicago%29&rft.au=Buckley%2C+Rachel+F&rft.au=Mormino%2C+Elizabeth+C&rft.au=Rabin%2C+Jennifer+S&rft.au=Hohman%2C+Timothy+J&rft.date=2019-05-01&rft.pub=American+Medical+Association&rft.issn=2168-6149&rft.eissn=2168-6157&rft.volume=76&rft.issue=5&rft.spage=542&rft_id=info:doi/10.1001%2Fjamaneurol.2018.4693&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-6149&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-6149&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-6149&client=summon